METTL3 and lung carcinoma: Overexpression of METTL3 in lung cancer cells activates the PI3K/AKT/mTOR pathway and mTOR-mediated protein synthesis, promotes the proliferation and metastasis of cancer cells, and is a poor prognostic factor for lung cancer patients [116].